Related Experiment Video
Updated: Dec 14, 2025

07:03
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.4K
Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
1Department of Endocrinology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China; Department of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong 250021, China; Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong 250021, China; Institute of Endocrinology and metabolism, Shandong Academy of Clinical Medicine, Jinan, Shandong 250021, China.
Ebiomedicine
|July 23, 2020
Abstract
No abstract available in PubMed .

